CAR-T Cells Target Alzheimer’s Plaques
April 6, 2026
Engineered immune cells clear amyloid and improve brain health in mice, offering a new direction for neurodegenerative therapy
1 min read
False
Advertisement
Latest
Trends and Challenges in Nitrosamine Testing: Part One – Scoping the Problem
April 3, 2026
In the first part of a new analytical science-focused series about all things nitrosamines, five experts share their first experiences, understanding of the danger, and comparisons with other industries
CAR Tregs Move Into Neurodegeneration
April 3, 2026
New review maps how engineered regulatory T cells could calm brain inflammation in Alzheimer’s, Parkinson’s, ALS, and multiple sclerosis
1 min read
CRISPR “Gene Drive” Reverses Antibiotic Resistance in Bacteria
April 2, 2026
Population-wide editing system strips resistance genes – even inside hard-to-treat biofilms
2 min read
Could Mass Spec Overcome the CAR T Solid Tumor Barrier?
April 1, 2026
Joey Sheff explains how proteomics is revealing targets, guiding CAR design, and predicting function in solid tumors.
6 min read
From One Stem Cell to Millions of Cancer Killers
April 1, 2026
A three-step engineering strategy generates vast numbers of potent NK immune cells – potentially slashing the cost and scaling of cancer immunotherapy
1 min read
AstraZeneca Deepens China Cell Therapy Push
March 31, 2026
New Shanghai manufacturing base and innovation center will support CAR-T production and a broader UK-China life sciences collaboration
1 min read
Resilience and Reinvention: Biotech’s Year of Maturity
By Audrey Greenberg
March 30, 2026
From capital scarcity to clinical impact, execution and partnerships are redefining the industry’s next chapter.
5 min read
Mapping Carbon Hotspots in Pharma Supply Chains
March 30, 2026
New framework combining LCA and network analysis reveals hidden leverage points for decarbonization in complex drug supply networks
1 min read
CRISPR Enables In Vivo CAR T Cell Production
March 30, 2026
In vivo gene editing strategy generates CAR T cells directly inside the body – sidestepping costly manufacturing
1 min read
